GLP-1 therapy, often used to aid in weight loss and blood sugar management, works by mimicking the effects of glucagon-like peptide-1 (GLP-1)
At the molecular level, it modulates the expression of over 4,000 human genes, roughly 6% of the genome, according to a 2012 Broad Institute Connectivity Map analysis published by Pickart, Campbell, and colleagues
While specific protocols vary by laboratory, a common preclinical starting point involves reconstituting the 5mg vial with 1mL of bacteriostatic water to yield a 5mg/mL concentration
While this represents a reasonable duration for clinical trials, it provides limited information about safety with years-long continuous use
The scar tissue can negatively affect how the medication will work